Attenuation of microRNA-1 derepresses the cytoskeleton regulatory protein twinfilin-1 to provoke cardiac hypertrophy

MicroRNAs are involved in several aspects of cardiac hypertrophy, including cardiac growth, conduction, and fibrosis. However, their effects on the regulation of the cardiomyocyte cytoskeleton in this pathological process are not known. Here, with microRNA microarray and small RNA library sequencing, we show that microRNA-1 (miR-1) is the most abundant microRNA in the human heart. By applying bioinformatic target prediction, a cytoskeleton regulatory protein twinfilin-1 was identified as a potential target of miR-1. Overexpression of miR-1 not only reduced the luciferase activity of the reporter containing the 3′ untranslated region of twinfilin-1 mRNA, but also suppressed the endogenous protein expression of twinfilin-1, indicating that twinfilin-1 is a direct target of miR-1. miR-1 was substantially downregulated in the rat hypertrophic left ventricle and phenylephrine-induced hypertrophic cardiomyocytes, and accordingly, the protein level of twinfilin-1 was increased. Furthermore, overexpression of miR-1 in hypertrophic cardiomyocytes reduced the cell size and attenuated the expression of hypertrophic markers, whereas silencing of miR-1 in cardiomyocytes resulted in the hypertrophic phenotype. In accordance, twinfilin-1 overexpression promoted cardiomyocyte hypertrophy. Taken together, our results demonstrate that the cytoskeleton regulatory protein twinfilin-1 is a novel target of miR-1, and that reduction of miR-1 by hypertrophic stimuli induces the upregulation of twinfilin-1, which in turn evokes hypertrophy through the regulation of cardiac cytoskeleton.

[1]  M. Latronico,et al.  microRNAs in heart disease: putative novel therapeutic targets? , 2010, European heart journal.

[2]  Yue Li,et al.  Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. , 2010, European heart journal.

[3]  T. Golub,et al.  MicroRNA-1 Negatively Regulates Expression of the Hypertrophy-Associated Calmodulin and Mef2a Genes , 2009, Molecular and Cellular Biology.

[4]  M. Moser,et al.  Two biochemically distinct and tissue-specific twinfilin isoforms are generated from the mouse Twf2 gene by alternative promoter usage. , 2009, The Biochemical journal.

[5]  Jian-Fu Chen,et al.  microRNAs and muscle disorders , 2009, Journal of Cell Science.

[6]  E. Olson,et al.  Toward microRNA-based therapeutics for heart disease: the sense in antisense. , 2008, Circulation research.

[7]  Y. Pinto,et al.  Conditional Dicer Gene Deletion in the Postnatal Myocardium Provokes Spontaneous Cardiac Remodeling , 2008, Circulation.

[8]  Yanjie Lu,et al.  Down-regulation of miR-1/miR-133 contributes to re-expression of pacemaker channel genes HCN2 and HCN4 in hypertrophic heart. , 2008, The Journal of Biological Chemistry.

[9]  A. Goldman,et al.  Structure of the actin-depolymerizing factor homology domain in complex with actin , 2008, The Journal of cell biology.

[10]  E. Olson,et al.  MicroRNAs flex their muscles. , 2008, Trends in genetics : TIG.

[11]  E. Olson,et al.  An intragenic MEF2-dependent enhancer directs muscle-specific expression of microRNAs 1 and 133 , 2007, Proceedings of the National Academy of Sciences.

[12]  Phillip A. Sharp,et al.  miRNA Profiling of Naïve, Effector and Memory CD8 T Cells , 2007, PloS one.

[13]  Q. Zhai,et al.  SIRT1 improves insulin sensitivity under insulin-resistant conditions by repressing PTP1B. , 2007, Cell metabolism.

[14]  C. Sander,et al.  A Mammalian microRNA Expression Atlas Based on Small RNA Library Sequencing , 2007, Cell.

[15]  C. Croce,et al.  MicroRNA-133 controls cardiac hypertrophy , 2007, Nature Medicine.

[16]  Xiaoxia Qi,et al.  Control of Stress-Dependent Cardiac Growth and Gene Expression by a MicroRNA , 2007, Science.

[17]  Michael T. McManus,et al.  Dysregulation of Cardiogenesis, Cardiac Conduction, and Cell Cycle in Mice Lacking miRNA-1-2 , 2007, Cell.

[18]  A. Annila,et al.  Structural basis and evolutionary origin of actin filament capping by twinfilin , 2007, Proceedings of the National Academy of Sciences.

[19]  Danish Sayed,et al.  MicroRNAs Play an Essential Role in the Development of Cardiac Hypertrophy , 2007, Circulation research.

[20]  E. Wentzel,et al.  A Hexanucleotide Element Directs MicroRNA Nuclear Import , 2007, Science.

[21]  Christopher M. Player,et al.  Large-Scale Sequencing Reveals 21U-RNAs and Additional MicroRNAs and Endogenous siRNAs in C. elegans , 2006, Cell.

[22]  E. Olson,et al.  A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure , 2006, Proceedings of the National Academy of Sciences.

[23]  P. Lappalainen,et al.  Mammalian twinfilin sequesters ADP‐G‐actin and caps filament barbed ends: implications in motility , 2006, The EMBO journal.

[24]  Xuemei Chen,et al.  Methylation Protects miRNAs and siRNAs from a 3′-End Uridylation Activity in Arabidopsis , 2005, Current Biology.

[25]  Yong Zhao,et al.  Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis , 2005, Nature.

[26]  A. Zeiher,et al.  Concentric left ventricular remodeling in endothelial nitric oxide synthase knockout mice by chronic pressure overload. , 2005, Cardiovascular research.

[27]  Shuang Huang,et al.  Involvement of MicroRNA in AU-Rich Element-Mediated mRNA Instability , 2005, Cell.

[28]  Anton J. Enright,et al.  Human MicroRNA Targets , 2004, PLoS biology.

[29]  R. Giegerich,et al.  Fast and effective prediction of microRNA/target duplexes. , 2004, RNA.

[30]  J. Cooper,et al.  Biological role and structural mechanism of twinfilin–capping protein interaction , 2004, The EMBO journal.

[31]  E. Olson,et al.  Hypertrophy of the heart: a new therapeutic target? , 2004, Circulation.

[32]  D. Bartel MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[33]  M. Salminen,et al.  Mammals Have Two Twinfilin Isoforms Whose Subcellular Localizations and Tissue Distributions Are Differentially Regulated* , 2003, Journal of Biological Chemistry.

[34]  S. Miyamoto,et al.  Initiation and Transduction of Stretch-induced RhoA and Rac1 Activation through Caveolae , 2003, Journal of Biological Chemistry.

[35]  R. Tuma,et al.  The two ADF-H domains of twinfilin play functionally distinct roles in interactions with actin monomers. , 2002, Molecular biology of the cell.

[36]  T. Tuschl,et al.  Identification of Tissue-Specific MicroRNAs from Mouse , 2002, Current Biology.

[37]  P. Mattila,et al.  Twinfilin is required for actin-dependent developmental processes in Drosophila , 2001, The Journal of cell biology.

[38]  J. Cooper,et al.  Interactions with PIP2, ADP-actin monomers, and capping protein regulate the activity and localization of yeast twinfilin , 2001, The Journal of cell biology.

[39]  R. Schwartz,et al.  βl integrin and organized actin filaments facilitate cardiomyocyte‐specific RhoA‐dependent activation of the skeletal α‐actin promoter , 2001 .

[40]  W. Schaper,et al.  Increased expression of cytoskeletal, linkage, and extracellular proteins in failing human myocardium. , 2000, Circulation research.

[41]  Petri Auvinen,et al.  Mouse A6/Twinfilin Is an Actin Monomer-Binding Protein That Localizes to the Regions of Rapid Actin Dynamics , 2000, Molecular and Cellular Biology.

[42]  D. Drubin,et al.  Regulation of the Cortical Actin Cytoskeleton in Budding Yeast by Twinfilin, a Ubiquitous Actin Monomer-sequestering Protein , 1998, The Journal of cell biology.

[43]  Minoru Hongo,et al.  MLP-Deficient Mice Exhibit a Disruption of Cardiac Cytoarchitectural Organization, Dilated Cardiomyopathy, and Heart Failure , 1997, Cell.

[44]  R. Schwartz,et al.  beta1 integrin and organized actin filaments facilitate cardiomyocyte-specific RhoA-dependent activation of the skeletal alpha-actin promoter. , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[45]  S. Kitano,et al.  Increased expression , 2022 .

[46]  K. Kinzler,et al.  A simplified system for generating recombinant adenoviruses. , 1998, Proceedings of the National Academy of Sciences of the United States of America.